Discover
DWTX
Dogwood Therapeutics, Inc.
1.40
2 x 1.40
2 x 1.47
bid
ask
-
0.01
0.71%
2 @ 04:00 PM
1.45 +0.05 (3.57%)
| Ytd | -66.35% | |
| 1y | -75.00% |
1.40
day range
1.54
1.34
52 week range
6.82
| Open | 1.45 | Prev Close | 1.41 | Low | 1.40 | High | 1.54 | Mkt Cap | 47.59M |
| Vol | 66.32K | Avg Vol | 63.50K | EPS | 2.18 | P/E | 0.64 | Forward P/E | -0.43 |
| Beta | 1.92 | Short Ratio | 0.42 | Inst. Own | 3.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.90 | 200-d Avg | 2.18 | 1yr Est | 13.83 |
| Income Statement | |||
| Operating Expenses | 14.06M | ||
| Research and Development Expense | 3.25M | ||
| Selling, General and Administrative Expense | 1.63M | ||
| Operating Income | -14.06M | ||
| Interest Expense | 66.35K | ||
| Income Tax Expense | -2.48M | ||
| Net Income | -11.53M | ||
| Net Income Common Stock | -11.53M | ||
| Net Income Common Stock (USD) | -11.53M | ||
| Consolidated Income | -11.53M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -13.94M | ||
| Earning Before Interest & Taxes (USD) | -13.94M | ||
| Weighted Average Shares | 34.13M | ||
| Weighted Average Shares Diluted | 34.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.61M | ||
| Cash and Equivalents (USD) | 9.61M | ||
| Current Assets | 11.03M | ||
| Property, Plant & Equipment Net | 142.57K | ||
| Total Assets | 80.50M | ||
| Total Debt | 69.56K | ||
| Current Liabilities | 2.83M | ||
| Debt Non-Current | 69.56K | ||
| Total Liabilities | 12.13M | ||
| Accumulated Retained Earnings (Deficit) | -124.59M | ||
| Accumulated Other Comprehensive Income | -2.99M | ||
| Shareholders Equity | 68.37M | ||
| Shareholders Equity (USD) | 68.37M | ||
| Assets Non-Current | 69.47M | ||
| Total Debt (USD) | 69.56K | ||
| Deferred Revenue | 37.56K | ||
| Goodwill and Intangible Assets | 69.31M | ||
| Liabilities Non-Current | 9.30M | ||
| Trade and Non-Trade Payables | 411.52K | ||
| Tax Liabilities | 9.20M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.69K | ||
| Net Cash Flow from Financing | 23.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.61M | ||
| Net Cash Flow from Operations | -3.61M | ||
| Effect of Exchange Rate Changes on Cash | -6.74K | ||
| Share Based Compensation | 543.20K | ||